Krónikus limfoid leukémia (CLL): vizsgálatok itt: Olaszország
47 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 16.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Where
- Alexandria, Bologna, Meldola, Milan, Reggio Emilia
- Életkor
- 18 év and over
- People
- 737 worldwide
- Run by
- Loxo Oncology, Inc.
See details and how to joinNCT05254743 · EU 2023-507699-38-00 - No phaseNot yet taking people in OlaszországInnovative 3D Preclinical Models for Mature B-cell Malignancies to Advance Personalized Immuno and Combination Therapies
- Where
- Milan
- Életkor
- 18 év and over
- People
- 64
- Run by
- IRCCS San Raffaele
See details and how to joinNCT07759661 - 1. fázisTaking peopleStudy Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Where
- Brescia, Milan, Perugia
- Életkor
- 18 év and over
- People
- 54 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2022-501876-24-00 - 1. fázisTaking peopleA Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- Where
- Bologna, Brescia, Milan, Rome
- Életkor
- 18 év and over
- People
- 572 worldwide
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT05131022 · EU 2023-510541-25-00 - 3. fázisTaking peopleGlobal Trial in APG2575 for Patients With CLL/SLL
- Where
- Aviano, Brescia, Ferrara, Genoa, Lecce, Meldola, Milan, Padova, Perugia, Piacenza, Ravenna, Reggio Emilia, Rimini, Rome, Rozzano, Turin, Varese
- Életkor
- 18 év to 99 év
- People
- 400 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06104566 · EU 2023-508005-24-00 - 2. fázisTaking peopleA Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
- Where
- Milan, Novara, Padova
- Életkor
- 18 év and over
- People
- 108 worldwide
- Run by
- Curis, Inc.
See details and how to joinNCT07271667 · EU 2025-523600-68-00 - 3. fázisBefejeződöttA Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)
- Where
- Candiolo, Florence, Genoa, Parma, Pavia, Ravenna, Rome, Terni
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- Dizal Pharmaceuticals
See details and how to joinNCT07139873 · EU 2025-522669-32-00 - 2. fázisTaking peopleZanubritnib and anti-MAG neuropathy
- Where
- Genoa, Milan, Padova, Pavia, Rome, Rozzano, Trieste, Turin
- Életkor
- 18 év and over
- People
- 50
- Run by
- Azienda Ospedaliera di Padova
See details and how to joinNCT07392229 · EU 2025-523091-23-00 - 4. fázisTaking peopleA Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
- Where
- Bologna, Milan
- Életkor
- 18 év and over
- People
- 787 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06876649 - 4. fázisTaking peopleA Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
- Where
- Bologna, Milan
- Életkor
- 18 év and over
- People
- 279 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06876662 - No phaseTaking peopleINTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)
- Where
- Palermo, Perugia
- Életkor
- 1 év and over
- People
- 300
- Run by
- Azienda Ospedaliero-Universitaria di Parma
See details and how to joinNCT07403630 - 1. fázisTaking peopleStudy of SGR-1505 in Mature B-Cell Neoplasms
- Where
- Alexandria, Milan, Turin, Verona
- Életkor
- 18 év and over
- People
- 98 worldwide
- Run by
- Schrödinger, Inc.
See details and how to joinNCT05544019 · EU 2023-505204-34-00 - 2. fázisTaking peopleStudy to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
- Where
- Terni, Turin
- Életkor
- 18 év and over
- People
- 75 worldwide
- Run by
- AbbVie
See details and how to joinNCT04895436 · EU 2023-504599-10-00 - No phaseTaking peopleLEF1 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A MARKER FOR DIAGNOSIS AND SURVIVAL PREDICTION
- Where
- Bologna
- Életkor
- 18 év and over
- People
- 350
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT07313982 - No phaseTaking peopleStudy on the Diagnosis and Management of CLL in Italy by GIMEMA
- Where
- Alessandria, Brescia, Brindisi, Candiolo, Florence, Messina, Mestre, Milan, Piacenza, Ragusa, Roma, Salerno, San Giovanni Rotondo, Siena, Terni, Torino, Treviso, Trieste, Vicenza
- Életkor
- 18 év and over
- People
- 12 500
- Run by
- Gruppo Italiano Malattie EMatologiche dell'Adulto
See details and how to joinNCT04867915 - 2. fázisTaking peopleIbrutinib and Obinutuzumab as first-line treatment for patients with Chronic Lymphocytic Leukemia
- Where
- Brescia, Milan, Padova, Palermo, Terni, Turin
- Életkor
- 18 év and over
- People
- 53
- Run by
- Ospedale San Raffaele S.r.l.
See details and how to join2024-514824-18-00 - No phaseNot yet taking people in OlaszországBiological and Clinical Efficacy of Shingrix in Patients With CLL
- Where
- Varese
- Életkor
- 18 év and over
- People
- 312
- Run by
- Gruppo Italiano Malattie EMatologiche dell'Adulto
See details and how to joinNCT06364033 - 1/2. fázisTaking peopleAllogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia
- Where
- Bergamo, Monza
- Életkor
- 1 év and over
- People
- 29
- Run by
- Fondazione Matilde Tettamanti Menotti De Marchi Onlus
See details and how to joinNCT05869279 · EU 2023-505511-20-00 - 2. fázisTaking peopleIbrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL
- Where
- Alessandria, Bari, Brescia, Cagliari, Castelfranco Veneto, Catania, Cosenza, Cuneo, Ferrara, Florence, Genoa, Lecce, Milan, Milano, Modena, Novara, Padova, Parma, Pavia, Perugia, Reggio Calabria, Rome, Trieste, Turin, Varese, Verona
- Életkor
- 18 év and over
- People
- 45
- Run by
- Gruppo Italiano Malattie EMatologiche dell'Adulto
See details and how to joinNCT05694312 · EU 2023-509793-38-00 - 2. fázisTaking peopleVenetoclax, Rituximab and Ibrutinib in TN Patients With CLL Undetectable Minimal Residual Disease (uMRD) in Treatment-naïve Patients With Chronic Lymphocytic Leukemia (CLL)
- Where
- Milan
- Életkor
- 18 év to 65 év
- People
- 55
- Run by
- Paolo Ghia
See details and how to joinNCT04758975 - 2. fázisTaking peopleFixed-duration Therapy With Ibrutinib and Obinutuzumab (GA-101) in Treatment-naïve Patients With CLL
- Where
- Milan
- Életkor
- 18 év and over
- People
- 53
- Run by
- Paolo Ghia
See details and how to joinNCT04908228 - 1/2. fázisTaking peopleSafety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
- Where
- Aviano, Meldola, Milan, Pavia, Verona
- Életkor
- 18 év and over
- People
- 84 worldwide
- Run by
- Kartos Therapeutics, Inc.
See details and how to joinNCT04502394